You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

Recruiting
  • Ewing Sarcoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 31, 2022

Small Cell Lung Cancer Trial in Boston (Olaparib, Temozolomide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Jan 24, 2022

Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • Rhabdomyosarcoma
  • Boston, Massachusetts
  • +4 more
Oct 27, 2021

SCLC After Initial Treatment Failure

Not yet recruiting
  • Small-cell Lung Cancer
    • (no location specified)
    Mar 8, 2021

    Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

    Not yet recruiting
    • Rhabdomyosarcoma
    • Palo Alto, California
    • +2 more
    Aug 27, 2023

    Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

    Active, not recruiting
    Has Results
    • Brain Stem Glioma
    • +4 more
    • Bevacizumab
    • +2 more
    • Birmingham, Alabama
    • +136 more
    Oct 15, 2022

    Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

    Completed
    Has Results
    • Ewing's Sarcoma
    • Vigil
    • +4 more
    • Little Rock, Arkansas
    • +5 more
    Dec 20, 2022

    Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

    Completed
    Has Results
    • Melanoma (Skin)
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jun 13, 2022

    Primary CNS Lymphoma Trial in Worldwide (Rituximab, Methotrexate, Procarbazine)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • Aarhus, Denmark
    • +34 more
    Nov 4, 2022

    Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

    Terminated
    Has Results
    • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
    • Chemotherapy with Temodar.
    • Radiation therapy
    • Baltimore, Maryland
      Ummc Msgcc
    Dec 1, 2022

    Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Rochester (radiation, other, biological, drug, procedure)

    Recruiting
    • Glioblastoma
    • +2 more
    • External Beam Radiation Therapy
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 4, 2022

    Glioblastoma Trial in Pittsburgh (Radiation Therapy, Temozolomide Oral Product)

    Recruiting
    • Glioblastoma
    • Radiation Therapy
    • Temozolomide Oral Product
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center, Radiation Oncology
    Jan 6, 2022

    Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 22, 2022

    Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

    Active, not recruiting
    • Malignant Neoplasms of Brain
    • tetanus toxoid
    • +2 more
    • Durham, North Carolina
      Duke University Medical Center
    Aug 16, 2022

    Glioblastoma, Recurrence, Progression Trial in Japan (Temozolomide, Bevacizumab)

    Recruiting
    • Glioblastoma
    • +2 more
    • Nagoya, Aichi, Japan
    • +36 more
    Aug 31, 2021

    Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

    Recruiting
    • Gliosarcoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Glioblastoma Multiforme, Adult, Glioblastoma, IDH-mutant Trial (Dose escalation + Reduced Margin Adaptive Radiotherapy)

    Not yet recruiting
    • Glioblastoma Multiforme, Adult
    • Glioblastoma, IDH-mutant
    • Dose escalation + Reduced Margin Adaptive Radiotherapy
    • (no location specified)
    Oct 3, 2022

    Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate

    Recruiting
    • Glioma
    • pre-operative abemaciclib
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Glioblastoma, Cancer of Brain and Nervous System, Glioblastoma Multiforme Trial in Stanford (Temozolomide, Stereotactic

    Completed
    Has Results
    • Glioblastoma
    • +2 more
    • Stanford, California
      Stanford University School of Medicine
    Aug 4, 2021

    Brain and CNS Tumors Trial in Worldwide (concomitant temozolomide (TMZ), radiotherapy, procarbazine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • concomitant temozolomide (TMZ)
    • +5 more
    • Birmingham, Alabama
    • +277 more
    Mar 22, 2022

    Glioblastoma Trial in Ann Arbor (Dose-Intensified Radiotherapy, Temozolomide, Adjuvant temozolomide)

    Recruiting
    • Glioblastoma
    • Dose-Intensified Radiotherapy
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Dec 16, 2021

    High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

    Recruiting
    • High Grade Glioma
    • LITT
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    Jan 5, 2023

    Glioblastoma Multiforme Trial in United States (Radiation therapy, Temozolomide, Bevacizumab)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Radiation therapy
    • +3 more
    • Huntsville, Alabama
    • +12 more
    Nov 8, 2021

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

    Completed
    Has Results
    • Brain Cancer
    • Birmingham, Alabama
    • +124 more
    Mar 16, 2022